These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 30353021
1. Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation. Lee J, Park JY, Kim DG, Lee JY, Kim BS, Kim MS, Il Kim S, Kim YS, Huh KH. Sci Rep; 2018 Oct 23; 8(1):15629. PubMed ID: 30353021 [Abstract] [Full Text] [Related]
5. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment. Nakamoto S, Kanda T, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, Takeda Y, Mimura N, Iseki T, Wu S, Arai M, Imazeki F, Saito K, Shirasawa H, Yokosuka O. Int J Mol Sci; 2014 Nov 21; 15(11):21455-67. PubMed ID: 25421241 [Abstract] [Full Text] [Related]
6. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation. Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A. Biol Blood Marrow Transplant; 2010 Jun 21; 16(6):809-17. PubMed ID: 20060484 [Abstract] [Full Text] [Related]
7. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure. Wong GL, Wong VW, Yuen BW, Tse YK, Yip TC, Luk HW, Lui GC, Chan HL. J Hepatol; 2020 Jan 21; 72(1):57-66. PubMed ID: 31499132 [Abstract] [Full Text] [Related]
8. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience. Papadopoulos N, Deutsch M, Manolakopoulos S, Bitsi C, Michalakeas H, Poulakidas H, Tsironi E, Giannouli S, Papatheodoridis GV, Koskinas J, Pectasides D. Eur J Gastroenterol Hepatol; 2017 Jan 21; 29(1):56-60. PubMed ID: 27669175 [Abstract] [Full Text] [Related]
15. Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation. Jeon JW, Kim SM, Cho H, Baek CH, Kim H, Shin S, Kim YH, Han DJ, Kim SB. Transplantation; 2018 Oct 21; 102(10):1717-1723. PubMed ID: 29621059 [Abstract] [Full Text] [Related]
18. Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients. Kim J, Chung SJ, Sinn DH, Lee KW, Park JB, Huh W, Lee JE, Jang HR, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. J Viral Hepat; 2020 Jul 21; 27(7):739-746. PubMed ID: 32057171 [Abstract] [Full Text] [Related]